Home / ATXI : OTC

AI Analysis Fundamentals Valuation Video Analysis News Similar

AI Analysis

How does ATXI make money? Does ATXI have pricing power? What's the Earnings Whisper? Will ATXI profit more as the business scales? What is ATXI's management track record? Is ATXI's current price justified?

Avenue Therapeutics, Inc.

$0.54 -$0.15 (-21.27%)

OTC · 14 Sep 2026 13:31 UTC

Previous Close

$0.6

Day Range

$0.54$0.61

Year Range

$0.15$0.97

Market Cap

1.78M

AVG Volume

4.24K

Trailing/Forward PE

-0.64/-

PEG ratio

-0.03

Dividend Yield

Next Earnings Date

2026-11-13

Primary Exchange

Other OTC

Revenue (USD) · TTM

ATXI Revenue (USD) · TTM by quarter
Period	Revenue (USD) · TTM
26 Q2	0
26 Q1	1.4M
25 Q4	1.4M
25 Q3	1.4M
25 Q2	1.4M
25 Q1	0
24 Q4	0
24 Q3	0
24 Q2	0
24 Q1	0

Net Income (USD) · TTM

ATXI Net Income (USD) · TTM by quarter
Period	Net Income (USD) · TTM
26 Q2	-2.78M
26 Q1	-1.75M
25 Q4	-2.91M
25 Q3	-3.74M
25 Q2	-6.14M
25 Q1	-13.66M
24 Q4	-16.15M
24 Q3	-13.96M
24 Q2	-10.36M
24 Q1	-7.18M

Operating Income (USD) · TTM

ATXI Operating Income (USD) · TTM by quarter
Period	Operating Income (USD) · TTM
26 Q2	-3.1M
26 Q1	-2.1M
25 Q4	-3.29M
25 Q3	-3.93M
25 Q2	-6.36M
25 Q1	-9.48M
24 Q4	-11.28M
24 Q3	-11.8M
24 Q2	-10.72M
24 Q1	-11.82M

EBITDA (USD) · TTM

ATXI EBITDA (USD) · TTM by quarter
Period	EBITDA (USD) · TTM
26 Q2	-3.06M
26 Q1	-2.06M
25 Q4	-3.25M
25 Q3	-3.85M
25 Q2	-6.18M
25 Q1	-9.06M
24 Q4	-10.86M
24 Q3	-6.57M
24 Q2	-3.04M
24 Q1	-4.47M

Cash Flows (USD) · TTM

ATXI Cash Flows (USD) · TTM by quarter
Period	Cash Flows (USD) · TTM
26 Q2	-1.38M
26 Q1	-1.08M
25 Q4	-1.83M
25 Q3	-1.74M
25 Q2	-5.01M
25 Q1	-7.09M
24 Q4	-9.03M
24 Q3	-10.59M
24 Q2	-9.59M
24 Q1	-12M

EPS (USD) · TTM

ATXI EPS (USD) · TTM by quarter
Period	EPS (USD) · TTM
26 Q2	-0.85
26 Q1	-0.53
25 Q4	-0.94
25 Q3	3.82
25 Q2	2.11
25 Q1	-4.43
24 Q4	-11.53
24 Q3	-16.04
24 Q2	-9.26
24 Q1	-41.58

Expenses (USD) · TTM

ATXI Expenses (USD) · TTM by quarter
Period	Expenses (USD) · TTM
26 Q2	3.1M
26 Q1	3.5M
25 Q4	4.69M
25 Q3	5.33M
25 Q2	7.76M
25 Q1	9.48M
24 Q4	11.28M
24 Q3	11.8M
24 Q2	11.72M
24 Q1	12.82M

Shares Outstanding (USD) · TTM

ATXI Shares Outstanding (USD) · TTM by quarter
Period	Shares Outstanding (USD) · TTM
26 Q2	-427K
26 Q1	-541K
25 Q4	-665K
25 Q3	-1.04M
25 Q2	-1.21M
25 Q1	-1.23M
24 Q4	-1.24M
24 Q3	-1.02M
24 Q2	-1.25M
24 Q1	-1.09M

Employee Count

ATXI Employee Count by quarter
Period	Employee Count
2025	1
2024	2
2023	3
2022	2
2021	4
2020	4
2019	4
2018	6
2017	2

Free Cash Flow Yield

ATXI Free Cash Flow Yield by quarter
Period	Free Cash Flow Yield
Sep 26	-70%
Sep 26	-77.14%
Aug 26	-92.93%
Aug 26	-163.06%
Aug 26	-163.06%
Aug 26	-164.65%
Jul 26	-84.97%
Jul 26	-119.51%
Jul 26	-131.77%
Jul 26	-103.33%
Jul 26	-108%
Jun 26	-117.65%
Jun 26	-101.19%
Jun 26	-102.94%
Jun 26	-93.45%
May 26	-109.8%
May 26	-136.75%
May 26	-109.8%
May 26	-62.15%
May 26	-96.28%
Apr 26	-88.7%
Apr 26	-106.44%
Apr 26	-130.09%
Apr 26	-167.26%
Mar 26	-188.79%
Mar 26	-188.79%
Mar 26	-228.13%
Mar 26	-248.86%
Feb 26	-288.16%
Feb 26	-365%
Feb 26	-365%
Feb 26	-285.77%
Jan 26	-271.04%
Jan 26	-135.32%
Jan 26	-78.21%
Jan 26	-73.2%
Jan 26	-79.82%
Dec 25	-85.31%
Dec 25	-83.99%
Dec 25	-84.19%
Dec 25	-71.2%
Nov 25	-71.61%
Nov 25	-70.27%
Nov 25	-72.03%
Nov 25	-210.01%
Oct 25	-218.79%
Oct 25	-221.78%
Oct 25	-215.76%
Oct 25	-221.84%
Oct 25	-225.04%
Sep 25	-196.91%
Sep 25	-207.25%
Sep 25	-192.11%
Sep 25	-214.32%
Aug 25	-276.37%
Aug 25	-271.6%
Aug 25	-276.37%
Aug 25	-478.99%
Aug 25	-518.93%
Jul 25	-600.98%
Jul 25	-568.35%
Jul 25	-653.99%
Jul 25	-702.29%
Jun 25	-992.96%
Jun 25	-799.02%
Jun 25	-1146.81%
Jun 25	-918.11%
May 25	-1095.74%
May 25	-1143.34%
May 25	-1084.54%
May 25	-2350.52%
May 25	-2238.59%
Apr 25	-2238.59%
Apr 25	-2128.37%
Apr 25	-2168.96%
Apr 25	-2168.04%
Mar 25	-2127.48%
Mar 25	-1827.69%
Mar 25	-837.5%
Mar 25	-675.13%
Feb 25	-601.48%
Feb 25	-486.49%
Feb 25	-486.49%
Feb 25	-542.32%
Jan 25	-486.49%
Jan 25	-350.07%
Jan 25	-357.64%
Jan 25	-365.54%
Jan 25	-321.18%
Dec 24	-341.04%
Dec 24	-373.8%
Dec 24	-367.57%
Dec 24	-359.58%
Nov 24	-307.73%
Nov 24	-329.17%
Nov 24	-342.81%
Nov 24	-391.52%
Nov 24	-382.78%
Oct 24	-389.74%
Oct 24	-406.36%

Price to Sales

ATXI Price to Sales by quarter
Period	Price to Sales
Jul 26	0.91
Jul 26	0.65
Jul 26	0.59
Jul 26	0.75
Jul 26	0.72
Jun 26	0.66
Jun 26	0.76
Jun 26	0.75
Jun 26	0.83
May 26	0.7
May 26	0.57
May 26	0.7
May 26	1.24
May 26	1.36
Apr 26	1.47
Apr 26	1.23
Apr 26	1
Apr 26	0.78
Mar 26	0.66
Mar 26	0.66
Mar 26	0.54
Mar 26	0.5
Feb 26	0.43
Feb 26	0.34
Feb 26	0.34
Feb 26	0.43
Jan 26	0.46
Jan 26	0.92
Jan 26	1.59
Jan 26	1.7
Jan 26	1.56
Dec 25	1.46
Dec 25	1.48
Dec 25	1.47
Dec 25	1.74
Nov 25	1.73
Nov 25	1.77
Nov 25	1.72
Nov 25	1.7
Oct 25	1.63
Oct 25	1.61
Oct 25	1.66
Oct 25	1.61
Oct 25	1.59
Sep 25	1.81
Sep 25	1.72
Sep 25	1.86
Sep 25	1.67
Aug 25	1.29
Aug 25	1.32
Aug 25	1.29

EV/EBITDA

ATXI EV/EBITDA by quarter
Period	EV/EBITDA
May 23	1438.3
Apr 23	1339.38
Apr 23	1452.42
Apr 23	1537.09
Apr 23	1748.79
Mar 23	1642.94

Price to Book

ATXI Price to Book by quarter
Period	Price to Book
Sep 26	3.47
Sep 26	3.15
Aug 26	2.62
Aug 26	1.49
Aug 26	1.49
Aug 26	1.48
Jul 26	1.07
Jul 26	0.76
Jul 26	0.69
Jul 26	0.88
Jul 26	0.84
Jun 26	0.77
Jun 26	0.9
Jun 26	0.88
Jun 26	0.97
May 26	0.82
May 26	0.66
May 26	0.82
May 26	1.46
May 26	1.04
Apr 26	1.13
Apr 26	0.94
Apr 26	0.77
Apr 26	0.6
Mar 26	0.4
Mar 26	0.4
Mar 26	0.33
Mar 26	0.3
Feb 26	0.26
Feb 26	0.21
Feb 26	0.21
Feb 26	0.26
Jan 26	0.28
Jan 26	0.56
Jan 26	0.97
Jan 26	1.03
Jan 26	0.95
Dec 25	0.89
Dec 25	0.9
Dec 25	0.9
Dec 25	1.06
Nov 25	1.06
Nov 25	1.08
Nov 25	1.05
Nov 25	0.84
Oct 25	0.81
Oct 25	0.8
Oct 25	0.82
Oct 25	0.8
Oct 25	0.79
Sep 25	0.9
Sep 25	0.85
Sep 25	0.92
Sep 25	0.83
Aug 25	0.64
Aug 25	0.65
Aug 25	0.64
Aug 25	0.63
Aug 25	0.59
Jul 25	0.51
Jul 25	0.54
Jul 25	0.47
Jul 25	0.43
Jun 25	0.31
Jun 25	0.38
Jun 25	0.27
Jun 25	0.33
May 25	0.28
May 25	0.27
May 25	0.28
May 25	0.21
May 25	0.22
Apr 25	0.22
Apr 25	0.23
Apr 25	0.22
Apr 25	0.22
Mar 25	0.3
Mar 25	0.35
Mar 25	0.77
Mar 25	0.95
Feb 25	1.07
Feb 25	1.32
Feb 25	1.32
Feb 25	1.18
Jan 25	1.32
Jan 25	1.83
Jan 25	1.79
Jan 25	1.75
Jan 25	2
Dec 24	1.88
Dec 24	1.71
Dec 24	1.74
Dec 24	1.78
Nov 24	2.08
Nov 24	1.95
Nov 24	1.87
Nov 24	0.64
Nov 24	0.65
Oct 24	0.64
Oct 24	0.62

No video analysis for this stock yet. Request one from our team.

News: ATXI

defenseworld.net · 13 Aug 2026

Avenue Therapeutics (NASDAQ:ATXI) and Collegium Pharmaceutical (NASDAQ:COLL) Head-To-Head Survey

Collegium Pharmaceutical (NASDAQ: COLL - Get Free Report) and Avenue Therapeutics (NASDAQ: ATXI - Get Free Report) are both small-cap healthcare companies, but which is the superior stock? We will contrast the two companies based on the strength of their earnings, risk, profitability, dividends, valuation, analyst recommendations and institutional ownership. Profitability This table compares Collegium Pharmaceutical and

AI Analysis

Avenue Therapeutics, Inc.

Video analysis: ATXI

News: ATXI

Avenue Therapeutics (NASDAQ:ATXI) and Collegium Pharmaceutical (NASDAQ:COLL) Head-To-Head Survey

Similar companies